Botanical species · safety record

Phyllanthus fraternus

The EFSA Compendium of Botanicals holds 9 constituent measurements for Phyllanthus fraternus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Phyllanthus fraternus G.L.Webster

9Constituent measurements

0Safety records

5Cited sources

2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Phyllanthus fraternus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Stem, root and leaves

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Alkaloids	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Lignans	Aerial part of plants	—	—	Unspecified	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Mehta, Kavit., Patel, B. N., Jain, B. K. Phytochemical analysis of leaf extract of Phyllanthus fraternus. Research Journal of Recent Sciences, 2013, p. 12-15.
Khatoon, S., Rai, V., Rawat, AKS., Mehrotra, S. Comparative pharmacognostic studies of three Phyllanthus species. Journal of ethnopharmacology, 2006, vol. 104, no. 1-2, p. 79-86. DOI
Jadoun, Anuruchi., Dwivedi, R. R., Harisha, C. R., Shukla, V. J. Pharmacognostical and pharmaceutical evaluation of selected bitter taste drugs. International Journal of Science Innovations and Discoveries, 2012, p. 253-259.
Singh, Amrita., Haider, Flora., Chaudhury, P. K., Mehrotra, N. K., Bagchi, G. D. Botanical and chemical studies on some medicinally important Phyllanthus species . Journal of medicinal and aromatic plant sciences, 2004, vol. 26, no. 4, p. 801-809.
Singh, S.K., Prakash, V. Toxicity assessment of Oxalis corniculata and phyllanthus fraternus plants. International journal of pharmacy and pharmaceutical sciences, 2014, vol. 6, no. 4, p. 388-392.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature